Abstract
Background and Aims: A recently published RCT by our group demonstrated clinical benefits of a chronic disease management (CDM) model including non-significant trends of both improved hospital utilization (increased proportion of elective versus emergency admission) and reduced mortality (40% reduction). In this follow-up study, our aim was to assess the relative cost effectiveness of the CDM model when compared to usual care during the 12-month study period, using incremental costs per death avoided as the primary outcome.
| Original language | English |
|---|---|
| Pages (from-to) | S121 |
| Number of pages | 1 |
| Journal | Journal of Hepatology |
| Volume | 66 |
| Issue number | S1 |
| DOIs | |
| Publication status | Published - 11 May 2017 |
Keywords
- Cost-effectiveness analysis
- Chronic disease management
- Chronic liver failure